SUBSCRIBE
SUBSCRIBE
News   FDA

Aerocrine Gets Reimbursement Win for Asthma Device in U.S.

January 18, 2012 | 
1 min read
Inflammatory airway disease specialist Aerocrine has gained expanded reimbursement coverage in the US for its Niox Mino device for managing asthma, and won marketing clearance for two new Asian markets.
FDA Approvals Europe
MORE ON THIS TOPIC
FDA
FDA’s AI Rollout Raises Questions Around Readiness, Legality
June 30, 2025
 · 
6 min read
 · 
Natalia Mesa
Facade of the FDA's office in Maryland
Approvals
Moderna, Merck, UroGen, Score RSV and Cancer Nods in June
June 30, 2025
 · 
9 min read
 · 
Tristan Manalac
Vaccines
ACIP Skips Votes on COVID and Moderna’s mRESVIA but Scrutinzes mRNA Vaccine Safety
June 27, 2025
 · 
2 min read
 · 
Jef Akst
Wooden blocks with arrow and error icon. Delays and disruptions, stop the process, critical error concept
Neurodegenerative disease
Edgewise Takes a Hit as FDA Blocks Accelerated Path for Becker Muscular Dystrophy Drug
June 27, 2025
 · 
2 min read
 · 
Tristan Manalac